Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIANCA: Tisagenlecleucel in pediatric relapsed/refractory mature B-cell non-Hodgkin lymphoma
2017-005019-15Phase 2Active
- Sponsor
- Novartis
- Start
- Aug 2018
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of tisagenlecleucel in non-Hodgkin lymphoma (NHL), sponsored by Novartis. Started Aug 2018; status: active.
02
Drugs
tisagenlecleucel
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2017-005019-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005019-15.